FindTrial
Sign In

Evaluate effect of fortified milk powder on iron deficiency anemia children

The nutritional and clinical evaluation of iron fortified milk powder intervention effect on iron deficiency anemia in childen

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ION-14005701
Enrollment
Unknown
Registered
2014-12-23
Start date
2015-01-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

iron deficiency anemia

Interventions

milk powder 1:iron fortified milk powder with Lactoferrin
milk powder 2:milk powder without Lactoferrin
Chalybeate:Ferplex
observation group:no intervention

Sponsors

Peking University Health Science Cente
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 3 Years

Inclusion criteria

Inclusion criteria: 1. 1-3 years old in the experiment period; 2. In accord with standard for clinical diagnosis of iron deficiency anemia: (1) laboratory examination of hemoglobin (Hb) less than 110g/L, mean corpuscular volume (MCV) less than 80fL, Mean corpuscular hemoglobin (MCH) less than 26pg, mean corpuscular hemoglobin concentration (MCHC) less than 310g/L; serum ferritin less than 12 mu g/L, serum iron less than 10.7 mol/L (60 g/L), total iron binding capacity more than 64.44 mol/L (360 g/dl). Hemoglobin (Hb) content is between 90~110g/L; (2) clinical manifestations (by a pediatric clinicians identification): ochrodermia, pale mucous membranes, easy fatigue.

Exclusion criteria

Exclusion criteria: 1. The diagnosed with blood system diseases, and the merger of the heart, the blood vessel of brain, liver, kidney, gastrointestinal tract and other serious diseases and mental disease patients; 2. The severely malnourished children; 3. with clear diagnosis disease which can lead to abnormal metabolism or absorption dysfunction; 4. recieve treatment due to diarrhea, respiratory tract infection, fever in the past 2 weeks; 5. allergic to oral iron or formula milk; 6. received surgical treatment in the past 3 months; 7. participated in other clinical studies in the past 3 months and interference on the results of this study 8. The short-term service drug to improve iron deficiency anemia or iron supplements contact history; 9. suffer from anemia caused by other factors rather than iron, and severe anemia.

Design outcomes

Primary

MeasureTime frame
Hb;SF;SI;TIBC;weight;—

Secondary

MeasureTime frame
MCV;MCH;MCHC;head circumference;chest;height;Dietary iron intake;—

Countries

China

Contacts

Public ContactChaiweizhong
chaipku@bjmu.edu.cn+86 13910074146

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026